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ABSTRACT
Introduction Frailty and pain are associated with adverse
patient clinical outcomes and healthcare system costs.
Frailty and pain can interact, such that symptoms of
frailty can make pain assessment difficult and pain can
exacerbate the progression of frailty. The prevalence of
frailty and pain and their concurrence in hospital settings
are not well understood, and patients with cognitive
impairment are often excluded from pain prevalence
studies due to difficulties assessing their pain. The aim
of this study is to determine the prevalence of frailty and
pain in adult inpatients, including those with cognitive
impairment, in an acute care private metropolitan hospital
in Western Australia.
Methods and analysis A prospective, observational,
single-day point prevalence, cross-sectional study of
frailty and pain intensity of all inpatients (excluding day
surgery and critical care units) will be undertaken. Frailty
will be assessed using the modified Reported Edmonton
Frail Scale. Current pain intensity will be assessed
using the PainChek smart-device application enabling
pain assessment in people unable to report pain due
to cognitive impairment. Participants will also provide
a numerical rating of the intensity of current pain and
the worst pain experienced in the previous 24 hours.
Demographic and clinical information will be collected
from patient files. The overall response rate of the survey
will be reported, as well as the percentage prevalence of
frailty and of pain in the sample (separately for PainChek
scores and numerical ratings). Additional statistical
modelling will be conducted comparing frailty scores with
pain scores, adjusting for covariates including age, gender,
ward type and reason for admission.
Ethics and dissemination Ethical approval has been
granted by Ramsay Health Care Human Research Ethics
Committee WA/SA (reference: 2038) and Edith Cowan
University Human Research Ethics Committee (reference:
2020–02008-SAUNDERS). Findings will be widely
disseminated through conference presentations, peer-
reviewed publications and social media.
Trial registration number ACTRN12620000904976.

Strengths and limitations of this study
►► This will be the first study to simultaneously assess

the point prevalence of frailty and pain across all
inpatients (excluding day surgery and critical care
wards) in an acute hospital.
►► The results of this study will inform future use of
routine frailty assessment and a technology-driven
assessment of pain.
►► Technology-driven assessment of pain will enable
pain intensity levels to be determined for patients
who cannot verbalise their pain or provide a numerical pain rating and who therefore have previously
been excluded from prevalence studies.
►► Exclusion of critical care wards (ie, intensive care
unit and coronary care unit) mean prevalence across
the entire hospital cannot be fully determined.

INTRODUCTION
The ageing population and increasing
number of frail older patients presents a challenge for health services. This patient group
often have multiple co-morbidities and symptoms including pain.1 2 Frailty and pain can
interact in such a way that symptoms of frailty
such as cognitive decline can make pain difficult to assess,3 and pain can exacerbate the
progression of frailty.4–6 Frailty and pain are
both associated with negative clinical and
patient outcomes,7 8 and significant costs to
the healthcare system,9 10 yet the prevalence
of each and their occurrence in hospital
settings are not well understood.1 11 12
Frailty is defined as ‘a medical syndrome
with multiple causes and contributors that is
characterised by diminished strength, endurance and reduced physiological function,
that increases an individual’s vulnerability
for increased dependency and/or death’
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compared with medical patients31; patients of a higher
socioeconomic status than public hospitals31; and more
patients aged 55–74 are treated in private hospitals than
other age groups32) which may impact the prevalence of
frailty or pain in the private hospital setting.
The prevalence of pain in hospital settings is also not
clearly understood. Clinical assessment of pain is traditionally reliant on patient self-
reports using numeric
ratings of pain intensity on a 0–10 scale33 or pain scales
developed for use with patients with a cognitive decline,
such as the Abbey Pain Scale.34 Prevalence studies investigating pain in hospitals have used similar tools but
the time frames over which patients are asked to rate
their pain have varied (eg, current pain vs any pain in
the last 24 hours). In a systematic review, Gregory and
McGowan11 identified five previous point prevalence
studies of current pain across entire hospitals35–39 that
reported rates of between 37.7% and 84%, and three
studies of pain in the last 24 hours which reported rates
between 52% and 65%.35 36 40 Given the self-report nature
of the commonly used tools, pain can be difficult to
accurately assess in patients with cognitive impairment,
meaning these patients are routinely excluded from pain
prevalence studies.35–37 39–42
In response to the problem of subjective pain assessment in cognitively impaired individuals, PainChek has
been developed and validated as an effective, technology
driven, multimodal, multiplatform and hybrid, pain
assessment tool. PainChek is a smart-device application
that evaluates pain in adults in 1 min using automated
facial recognition and analysis to identify pain-
related
facial microexpressions, together with a series of user
completed checklists of pain behaviours.43 44 It uses the
in-built cameras and processors of smart devices to assess
the presence of pain-associated facial muscle movements
using a 3 second video analysis of the individual’s face. The
application then guides the assessor through checklists of
pain behaviours, which include items related to changes
in vocalisations, movement, and behaviours enacted by
individuals during the experience of pain (figure 1).
The total of these behaviours informs the pain intensity
according to the following categories: no pain (0–6), mild
(7–11), moderate (12–15) and severe (≥16).44 45 Based on
a number of clinical studies (total participants n=74, 753
paired pain assessments) the PainChek application has
demonstrated sound psychometric validity and reliability
and clinical utility in people with moderate-
to-
severe
dementia.44–47 The prevalence of pain has not previously
been assessed across an entire hospital using a technology
driven assessment of pain. The use of such a device would
allow data to be collected from all participants including
those unable to provide a reliable self-report rating of
their pain.
The aim of the proposed study is to conduct a point
prevalence survey on frailty and pain of adult inpatients
in an acute private hospital in Western Australia. The
study will be the first worldwide to investigate the prevalence of frailty across the adult inpatients of an entire
Saunders R, et al. BMJ Open 2021;11:e046138. doi:10.1136/bmjopen-2020-046138
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[Morley, p393].13 Frailty is associated with increased
risk of postoperative complications, increased length of
hospital stay, functional dependency post-discharge, readmission to hospital and death during hospitalisation.8 14–16
One study identified an increase in healthcare costs of
between 54% and 101% concomitant with increasing
symptoms of frailty and costs of nursing care.9 Clinical
Practice Guidelines recommend routine frailty screening
for older adult patients.17
The difficulty in routinely assessing patients for frailty
and determining its prevalence is in part due to the
nature, design and administration of the assessment
tools. Many of the assessment tools such as the phenotype model18 are performance-based measures of physical
function which are lengthy and require specialist administration. Recently, self-report measures of function have
been developed, including the Reported Edmonton Frail
Scale (REFS)19 and the modified REFS (mod-REFS),20
which have been shown to provide a valid estimate of
frailty.19 21
A systematic review of community based cohort studies
estimated 10.7% of the older adult population are categorised as frail.22 Recent studies suggest the prevalence
of frailty is higher for hospitalised older adults, reporting
rates between 28% and 87%.23–28 The large degree of variability may be, in part, due to differences in the methods
of assessment of frailty, the lack of standardisation across
studies, differences in the medical conditions and ward
type included and variety of geographical locations. The
focus on older adult patients and/or limitation to specific
wards makes generalisation difficult and results do not
provide a complete picture of the hospital-wide prevalence of frailty.
Only two studies were located that reported the point
prevalence of frailty across all patients in an entire hospital.
Richards et al12 assessed frailty using the mod-REFS and
found the prevalence to be 48.8% in a tertiary hospital
in New Zealand. The prevalence of frailty was found
to increase significantly with age and differences were
found between admission types (eg, patients admitted to
a medical specialty were frailer than those admitted to a
surgical specialty12). Condon et al29 assessed frailty using
the Clinical Frail Scale30 and reported 52.2% prevalence
of frailty in an acute university hospital in Ireland. Given
the focus of the study was on incontinence, associations
with frailty were not fully explored, however, increased
frailty scores were associated with both increased urinary
and faecal incontinence.29 Despite the difference in
location (ie, New Zealand vs Ireland), these two studies
suggest that approximately half of all inpatients within
public hospitals are frail. However, the prevalence of
frailty across all patients within an Australian hospital
and within a private hospital setting has not previously
been examined. This is an important area to investigate
as private hospitals account for approximately 40% of all
hospitalisations in Australia31 and there are key demographic differences between public and private hospitals
(eg, private hospitals have a higher percentage of surgical
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Inclusion criteria
All acute care inpatients willing and able to provide
informed verbal consent.
►► All acute care inpatients who are unable to consent
due to cognitive impairment or inability to verbally
communicate, and have written proxy consent
provided.
►► Aged 18 years or over.
►►

Figure 1 PainChek assess facial microexpressions that
indicate the presence of pain. A pain intensity score is
calculated across six domains of pain assessment. The face
in this image is a royalty-free stock image freely available
from: https://www.istockphoto.com/photo/studio-portrait-ofa-senior-man-gm157718744-21971579

acute private hospital (excluding patients in day surgery
and critical care units), and the first across an entire
Australian hospital. In addition, the proposed study will
be the first point prevalence study of current pain across
an entire hospital using a technology driven assessment
of pain. Results of this study will provide an understanding of the distribution of frailty and pain and their
concurrence across the hospital setting and guide future
research into potential interventions.

METHODS AND ANALYSIS
Study design and setting
A prospective, observational, single-
day point prevalence, cross-
sectional study assessing frailty and pain
will be undertaken. The study will be conducted across
all non-critical care wards of an acute private metropolitan hospital in Perth, Western Australia. It is the largest
private hospital in Western Australia with 738 licensed
beds. The study will take place in late November 2020.
The Strengthening the Reporting of Observational
Studies in Epidemiology Statement Checklist will be used
to report the findings of the study.48
Recruitment
Potential participants will include all adult inpatients who
were hospitalised at or before 08:00 hours on the day of
data collection, excluding day procedure, intensive care
(ICUs) and coronary care units (CCUs). It is anticipated
there will be a maximum of 518 participants across 18
wards including surgical, medical, rehabilitation and
Saunders R, et al. BMJ Open 2021;11:e046138. doi:10.1136/bmjopen-2020-046138

Exclusion criteria
The patient will not participate in the study if any of the
following apply:
►► Admitted to day procedures unit.
►► Admitted to high-dependency areas (ICU, CCU).
►► Hospitalised after 08:00 hours.
►► Severe hearing impairment.
►► Severe intellectual disability.
►► Too unwell to participate.
►► Refuse consent.
Excluded patients will be noted and the reason for
exclusion recorded. If a patient or proxy who is declining
to participate volunteers a reason for their refusal that
reason will also be recorded.
Participant information sheets will be provided to inpatients in the 2 days prior to commencement of data collection. For patients admitted after 17:00 hours on the day
prior to data collection the participant information sheet
will be provided on the day of data collection.
Given the research is low risk, the interaction with the
patient is minor, and assessments of pain and frailty are
part of standard care, we will seek verbal consent from
patients with their response recorded by the data collector.
If a patient is unable to provide informed consent due
to cognitive impairment or inability to verbally communicate, written proxy consent will be sought from their
of-
kin following guidelines from the
guardian or next-
Western Australian Department of Health to adhere to
the requirements of the Western Australian Guardianship
and Administration Amendment (Medical Research)
Act 2020.49 On admission to the study site, patients are
routinely assessed using the 4AT (Assessment Test) for
the4at.
delirium and cognitive impairment (4AT; www.
com). For patients with a 4AT score of 4 or greater the
data collector will check the patient’s file for a cognitive
assessment (either the Mini-Mental State Examination50
or Montreal Cognitive Assessment51 (MMSE, MoCA)).
Where cognitive assessment indicates no cognitive impairment (MMSE ≥25; MoCA >25) consent will be sought
from the patient. Where cognitive assessment scores indicate severe cognitive impairment (MMSE <18; MoCA <10)
proxy consent will be sought. Where cognitive assessment
indicates mild-
moderate cognitive impairment (MMSE
18–24; MoCA 10–25) or if no cognitive assessment has
been performed the data collector will consult with the
patient’s medical team to determine if the patient has the
3
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Data collection
All data will be collected on a single day with approximately
15 min interactions with each participant. Data collectors
will work in pairs, with one data collector conducting the
pain and frailty assessments with the patient (or proxy
where necessary), while the other will access the patient’s
file to record demographic and clinical information.
Data collectors will be members of the research team,
registered nurses from the study hospital and nursing
students from the study university. All data collectors will
be required to complete a 2-hour training session on the
data collection protocol including the PainChek assessment no more than 7 days prior to data collection. Both
the mod-REFS and PainChek were developed for use by
non-health professionals. Evidence from previous studies
found excellent inter-rater reliability, on the REFS when
administered by two non-
medically trained research
scientists,19 and PainChek when administered by nurses
trained to administer the assessment,46 which suggests a
single assessment of each patient is sufficient.
On the day of data collection, before approaching
patients, the data collectors will meet with the ward nurse
manager to obtain a bed list of patients currently admitted
to the ward. The nurse manager will identify patients
too unwell to participate and those with an intellectual
disability, who will be excluded from the study. Prior to
approaching a patient, the data collectors will check the
patient’s 4AT score in the patient’s file (score <4 patient
will be approached, score ≥4 cognitive assessments will be
checked and proxy consent will be sought if required). If
a patient is absent from their bed space, data collectors
will return later in the day.
Each participant will have a pain and frailty assessment;
demographic and clinical data will also be collected.
During the pain and frailty assessments, data collectors
will enter the participant’s responses into a data collection
form in Qualtrics running on an iPad or iPad mini. Where
consent is sought from a proxy, the pain assessment will
be conducted with the patient only using PainChek, and
the frailty assessment will be completed by the proxy on
behalf of the patient.
Pain assessment
Current pain status will be assessed at rest for all participants using the PainChek application on an iPad or iPad
mini. PainChek uses a combination of automated facial
recognition and other clinical indicators to calculate a
pain intensity score. The score is based on the summation
of 42 indicators of pain across 6 domains (ie, Face, Voice,
Movement, Behaviour, Activity, Body) the presence of
which are scored as ‘yes’=1 and ‘no’=0. As part of its multidiamentional design, PainChek also captures specific data
on pain interference, which cover physical, emotional and
4

social aspects of pain experience. PainChek scores will be
stored in the PainChek cloud repository and entered into
the Qualtrics data collection form.
Following the PainChek assessment participants who
are able to self-report pain (ie, those without cognitive
decline) will be asked to give a numerical rating of the
intensity of their current pain and the worst pain they have
experienced in the last 24 hours. These will be conducted
using the routine verbal 0–10 Numerical Rating Scale
where 0 is ‘no pain at all’ and 10 is ‘worst possible pain’.
Frailty assessment
Frailty will be assessed using the mod-REFS which is a
13-item self-report questionnaire scored from 0 to 18.20
This tool was chosen as it is quick to administer (<10 min),
can assess frailty prior to an acute illness, is validated for
use in hospitals,20 and has previously been used to assess
the point prevalence of frailty in a hospital setting.12
Participants will be asked two additional questions on
their perceptions of their own frailty: (1) Do you consider
yourself to be frail? (yes/no) and (2) Based on the answer
to the last question, on a scale of 0–10 where 0 is ‘not
at all’ and 10 is ‘extremely’ how frail do you think you
are? In the case of participants requiring proxy consent
due to cognitive impairment the mod-REFS and frailty
questions will be completed by the proxy on behalf of the
participant.
Demographic and clinical data
Routine admission data will be collected from the patient
files including year of birth, gender, admission date,
indigenous status, admission type (elective or acute) and
admission mode (home or residential aged-care facility).
Clinical information including admitting diagnosis, active
medical conditions and analgesics (name, dose and time
of last dose) will also be collected from patient files.
Data reporting and analysis
The overall response rate of the survey will be reported
as a percentage of eligible patients. Reasons for exclusion
and the associated percentages will also be reported. The
distributions of demographic and clinical characteristics
will be described for the overall cohort using standard
summary statistics.
The percentage prevalence of frailty in the sample will
be calculated based on the mod-REFs score where a score
of 8 and above is classified as frail, and will also be calculated in terms of the severity of frailty for the classifications: not frail (0–5), apparently vulnerable (6–7), mild
frailty (8–9), moderate frailty (10–11) and severe frailty
(12–18).20 Prevalence will be reported across the whole
sample and by specialty (ie, medical, surgical, rehabilitation, mental health). Comparison between scores on the
mod-REFS and subjective perceptions of personal frailty
obtained from supplementary questions will be explored
(ie, do patients classified as severely frail on the mod-
REFS classify themselves as frail more often, and rate
their frailty higher, than those classified as moderately
Saunders R, et al. BMJ Open 2021;11:e046138. doi:10.1136/bmjopen-2020-046138
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capacity to consent or if proxy consent should be sought.
If a patient is unable to speak English a telephone translation service will be used to interpret the information
sheet, ask for consent and administer questionnaires.
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Data management
Data will be managed according to the Australian National
Statement on Ethical Conduct in Human Research (2007).
No identifying data will be collected. Participants will be
assigned a participant number based on their ward and
bed number. Hard copy data collection forms will be
stored in locked filing cabinets at the university accessible
only by research team members. The data and participant
information collected will be stored securely on University servers only accessible by research team members on
password protected computers. PainChek data will be
stored in a repository within the PainChek secure cloud
database. Data will only be accessible by the research team
members via a password protected Web Administration
Portal. Data may be made available to other researchers
for future research and may be published online according
to publisher’s requirements. All data will be destroyed after
7 years.
Patient and public involvement
Patients at the site are represented by a consumer representative from the hospital consumer advisory board. The
consumer representative was invited to be part of the project
at the commencement as a member of the research team
and was involved in the study design. The research questions were discussed with the team and the proposal that
included the research questions and outcome measures was
reviewed by the team.
As we will not be collecting any personal or contact information from the study participants, it will not be possible to
disseminate the research findings to them directly. However,
findings will be communicated via the hospital newsletter
and national hospital group newsletter and the PainChek
website. The consumer representative will be involved in
the discussions about the dissemination plan.
Saunders R, et al. BMJ Open 2021;11:e046138. doi:10.1136/bmjopen-2020-046138

ETHICS AND DISSEMINATION
Given the relationship between cognitive decline and
frailty it is important to include patients with cognitive
impairment in this study. Similarly, in order to measure
prevalence across the entire hospital it is important to
include inpatients admitted to the mental health wards.
The inclusion of participants with cognitive impairment
and mental illness requires particular consideration of the
consent procedures and risk of distress for these patients as
per the Australian National Statement on Ethical Conduct
in Human Research (2007). Patients in the mental health
wards of the study hospital are all admitted voluntarily and
can provide informed consent. Any refusal to participate
will be respected. Where cognitive impairment means a
patient is unable to provide informed consent, consent will
be sought from the patient’s legal guardian or next-of-kin.
If at any point a patient exhibits signs of distress, the assessment will cease, and nursing assistance will be sought.
This study has ethical approval from both the Ramsay
Health Care Human Research Ethics Committee for
Western Australia and South Australia (reference number:
2038) and the Edith Cowan University Human Research
Ethics Committee (reference: 2020–02008-SAUNDERS).
Results of this study will be disseminated at a number of
levels. A report of the study findings will be provided to the
study hospital and may be used to review its procedures and
to guide a larger prevalence study across all hospitals run
by the operator in Australia. Regardless of the outcomes,
it is our intention to publish the results of this study in a
peer-reviewed journal. Findings will also be presented at
Australian and international conferences. Publications
resulting from this study will be publicised through project
and departmental social media.
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available data from all participants will be included in the
primary statistical analysis. The analysis will involve the
use of regression models to identify important factors
related to the prevalence of frailty and pain reporting
point estimates and 95% CIs along with a p value of 0.05
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